As a clarification to this question, will the Indian and Chinese regulators be enforcing Q7A on their domestic manufacturers?

The FDA or their European or Japanese counterparts will definitely be using Q7A in China and
India for materials being imported into the ICH regions. Any intermediate or API imported into any
of the ICH regions would be expected to comply with Q7A, no matter where it originated.
However it is not currently expected that Indian or Chinese regulators will be enforcing Q7A on
APIs intended for consumption in India or China.